We calculated g-rate using PSA values while getting a drug for metastatic prostate cancer in US Veterans. We consistently show robust inverse correlation of g-rate and overall survival, now in 23,500 patients, expanding to 7 therapies for mPC. #asco2023#unmc#grate#ascoYIA
On #VeteransDay, we celebrate the Americans who have served and spotlight the work of #ConquerCancer researcher Dr. @HarshrajL, who is working to improve care for Veterans diagnosed with #ProstateCancer https://t.co/ROFrdwNNnC #PCSM
Ecstatic, honored and excited to be the recipient of @ASCO Young Investigator Award (#YIA)😃 and be amongst the "Brightest Minds in Cancer Research" !!!
Ever grateful to Dr. Tito Fojo for amazing mentorship and @Melodys88 for her unrelentless love and support! @sunydownstate
@DrBattiwalla But it may be better to give it to a patient who is positive with minimal symptoms to decrease viral loads to minimize transmission. What do you think?
@DrBattiwalla Interestingly the French paper of HCQ+ Azithromycin, while being phase 1 study with "technically 26" patients didn't have any clinical endpoints but had some decrease in viral load. Everyone is giving it to extremely sick patients and patients are still dying
At time of such anguish, I suddenly see governors talking about acting as if all(private and public) hospital systems are one regardless of patients' insurance, I guess they now #FeelTheBern of the viral pandemic.
@BernieSanders
The rate of tumor growth , g , is an excellent biomarker for overall survival (OS) in prostate cancer in real world data from US Veterans Affairs Medical Centers (VAMC).
poster -5074 #asco2019#pcsm#biomarker
.@AwesomeReview Passed my board exam!!! I am pretty sure could not have done it without your guidance! Thank you so much! Actually I aced it not just passed, like you said!!! #abim#awesomereview
We calculated tumor growth rates for > 5000 US Veterans with prostate ca to assess efficacy of Abiraterone and Enzalutamide: Growth rate correlates very highly with FDA gold standard, overall suvival! #ASCO18#BigDataAnalytics#bigdata#prostatecancer
https://t.co/dIR0XCa8x3
''Liberal oxygen therapy increases mortality without improving other patient-important outcomes.''
Mortality and morbidity in acutely ill adults treated with liberal versus conservative #oxygentherapy (IOTA): a systematic review and meta-analysis https://t.co/ll9cBJujKq